NeuroBo (NASDAQ: NRBO) Stock Skyrockets on FDA’s IND Approval for Obesity Drug
NeuroBo Pharmaceuticals (NASDAQ: NRBO) stock soared about 70% on Thursday after the FDA approved its Investigational New Drug (IND) application […]
NeuroBo (NASDAQ: NRBO) Stock Skyrockets on FDA’s IND Approval for Obesity Drug Read More »